Literature DB >> 3323884

Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice.

C Bieberich1, T Yoshioka, K Tanaka, G Jay, G Scangos.   

Abstract

The regulated expression of major histocompatibility complex class I antigens is essential for assuring proper cellular immune responses. To study H-2 class I gene regulation, we have transferred a foreign class I gene to inbred mice and have previously shown that the heterologous class I gene was expressed in a tissue-dependent manner. In this report, we demonstrate that these mice expressed the transgenic class I molecule on the cell surface without any alteration in the level of endogenous H-2 class I antigens. Skin grafts from transgenic mice were rapidly rejected by mice of the background strain, indicating that the transgenic antigen was expressed in an immunologically functional form. As with endogenous H-2 class I genes, the class I transgene was inducible by interferon treatment and suppressible by human adenovirus 12 transformation. Linkage analysis indicated that the transgene was not closely linked to endogenous class I loci, suggesting that trans-regulation of class I genes can occur for class I genes located outside the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323884      PMCID: PMC368069          DOI: 10.1128/mcb.7.11.4003-4009.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  A transcriptional enhancer and an interferon-responsive sequence in major histocompatibility complex class I genes.

Authors:  J Vogel; M Kress; G Khoury; G Jay
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

2.  Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.

Authors:  K Ozato; T H Hansen; D H Sachs
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

3.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors:  M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids.

Authors:  R Bernards; A Houweling; P I Schrier; J L Bos; A J Van der Eb
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

5.  Differential regulation of H-2 antigen expression in tumors and its biologic consequences.

Authors:  W Schmidt; A Alonso; L Leben; H Festenstein
Journal:  Transplant Proc       Date:  1981-12       Impact factor: 1.066

6.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

7.  DNA-mediated gene transfer of a circular plasmid into murine cells.

Authors:  K M Huttner; G A Scangos; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  7 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Tissue-specific expression of the HLA-DRA gene in transgenic mice.

Authors:  P Giacomini; A Ciucci; M R Nicotra; C Nastruzzi; G Feriotto; E Appella; R Gambari; L Pozzi; P G Natali
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Transgenic mouse model for central nervous system demyelination.

Authors:  T Yoshioka; L Feigenbaum; G Jay
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Extinction of JC virus tumor-antigen expression in glial cell--fibroblast hybrids.

Authors:  A H Beggs; R J Frisque; G A Scangos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.

Authors:  P Höglund; H G Ljunggren; C Ohlén; L Ahrlund-Richter; G Scangos; C Bieberich; G Jay; G Klein; K Kärre
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

6.  Cytolytic T cells recognize a chimeric MHC class I antigen expressed in influenza A infected transgenic mice.

Authors:  W A Jefferies; U Rüther; E F Wagner; S Kvist
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

7.  Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.

Authors:  P Höglund; R Glas; C Ohlén; H G Ljunggren; K Kärre
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.